GENEIUS BIOTECHNOLOGY INC has a total of 21 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and Singapore. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SEMENTIS LTD, MACLACHLAN IAN and CELLEX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 5 | |
#3 | Singapore | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Slanetz Alfred E | 17 |
#2 | Herrman Marissa A | 7 |
#3 | Nakagawa Terry Y | 7 |
#4 | Slanetz Alfred | 2 |
#5 | Terry Y Nakagawa | 1 |
#6 | Herrman Marissa | 1 |
#7 | Marissa A Herman | 1 |
#8 | Nakagawa Terry | 1 |
#9 | Alfred E Slanetz | 1 |
Publication | Filing date | Title |
---|---|---|
SG11201811745UA | T cell compositions for immunotherapy |